1. CD4+CXCR4+ T cells as a novel prognostic biomarker in patients with idiopathic inflammatory myopathy-associated interstitial lung disease. (1st December 2018) Authors: Wang, Kaiwen; Zhao, Jiangfeng; Chen, Zhiwei; Li, Ting; Tan, Xiaoming; Zheng, Yu; Gu, Liyang; Guo, Li; Sun, Fangfang; Wang, Haiting; Li, Jiajie; Wang, Xiaodong; Riemekasten, Gabriela; Ye, Shuang Journal: Rheumatology Issue: Volume 58:Number 3(2019) Page Start: 511 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. CD4+CXCR4+ T cells as a novel prognostic biomarker in patients with idiopathic inflammatory myopathy-associated interstitial lung disease. (22nd December 2018) Authors: Wang, Kaiwen; Zhao, Jiangfeng; Chen, Zhiwei; Li, Ting; Tan, Xiaoming; Zheng, Yu; Gu, Liyang; Guo, Li; Sun, Fangfang; Wang, Haiting; Li, Jiajie; Wang, Xiaodong; Riemekasten, Gabriela; Ye, Shuang Journal: Rheumatology Issue: Volume 58:Number 3(2019) Page Start: 557 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. Forced vital capacity predicts the survival of interstitial lung disease in anti-MDA5 positive dermatomyositis: a multi-centre cohort study. (25th March 2021) Authors: Wu, Wanlong; Xu, Wenwen; Sun, Wenjia; Zhang, Danting; Zhao, Jiangfeng; Luo, Qun; Wang, Xiaodong; Zhu, Feng; Zheng, Yu; Xue, Yu; Wan, Weiguo; Wu, Huaxiang; Han, Qian; Ye, Shuang Journal: Rheumatology Issue: Volume 61:Number 1(2022) Page Start: 230 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗